VALNEVA (EPA:VLA) | Finanzwire

BRIEF

published on 08/18/2025 at 07:05, 8 months 14 days ago

Valneva's IXCHIQ® Vaccine Authorized in Canada for Ages 12 and Older

Health Canada Valneva Vaccine Authorisation Chikungunya
PRESS RELEASE

published on 08/18/2025 at 07:00, 8 months 14 days ago

Valneva’s Chikungunya Vaccine IXCHIQ® Now Authorized in Canada for Individuals Aged 12 and Older
Valneva's Chikungunya Vaccine IXCHIQ® authorized in Canada for individuals aged 12 and older. Health Canada grants marketing authorization for disease prevention

Canada Health Valneva Vaccine Chikungunya
BRIEF

published on 08/12/2025 at 07:05, 8 months 20 days ago

Valneva's Half-Year 2025 Financial Report: Growth and Strategic Moves

Financial Results Strategic Partnerships Revenue Growth Cash Management Regulatory Updates
PRESS RELEASE

published on 08/12/2025 at 07:00, 8 months 20 days ago

Valneva Reports Half Year 2025 Financial Results and Provides Corporate Updates
Valneva SE reports €97.6 million revenues in H1 2025, confirms 2025 financial outlook. Highlights financial results, R&D progress, and commercial updates

Revenues Financial Results Valneva SE R&D Progress 2025 Outlook Commercial Updates
BRIEF

published on 08/07/2025 at 07:22, 8 months 25 days ago

Valneva Obtains FDA Lift of Ban on IXCHIQ®

FDA Valneva Chikungunya IXCHIQ® Vaccine Elderly People
PRESS RELEASE

published on 08/07/2025 at 07:17, 8 months 25 days ago

Valneva Announces Removal of FDA-Recommended Pause on Use of Chikungunya Vaccine IXCHIQ® in Elderly and Updates to the Prescribing Information
Valneva announces FDA's removal of recommended pause on Chikungunya Vaccine IXCHIQ® in elderly individuals and updates to the Prescribing Information, following EMA's recommendation. Updates reflect Serious Adverse Events and expanded Warnings and Precaution section

FDA Valneva Chikungunya Vaccine Prescribing Information Vaccine Updates
BRIEF

published on 07/28/2025 at 13:51, 9 months 4 days ago

Valneva SE: Positive Outlook Amid Chikungunya Concerns

Biotech Valneva SE Equity Research Chikungunya Vaccine Market
PRESS RELEASE

published on 07/28/2025 at 13:46, 9 months 4 days ago

Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research updates Valneva SE (FR0004056851) rating to Buy with a target price of €8.10 amidst global Chikungunya outbreak warning by WHO

First Berlin Equity Research BUY Rating Valneva SE Chikungunya Outbreak EUR 8.10 Target Price
BRIEF

published on 06/26/2025 at 07:05, 10 months 5 days ago

Valneva Secures Exclusive Vaccine Distribution in Germany with CSL Seqirus

Valneva Germany Market 2025 Sales Growth CSL Seqirus Vaccine Distribution
PRESS RELEASE

published on 06/26/2025 at 07:00, 10 months 5 days ago

Valneva Announces Exclusive Vaccine Marketing and Distribution Agreement for Germany with CSL Seqirus
Valneva SE announces exclusive vaccine marketing and distribution agreement for Germany with CSL Seqirus. CSL to commercialize Valneva's vaccines IXCHIQ®, IXIARO®, and DUKORAL®

Distribution Agreement Germany Valneva SE CSL Seqirus Vaccine Marketing

Published on 05/02/2026 at 01:30, 10 minutes ago

Uraniumx Reports Strong Financial Position Ahead of Spring Drill Program
Published on 05/02/2026 at 00:50, 50 minutes ago

CoTec Announces Annual Stock Option, Restricted Share Unit And Deferred Share Unit Grants
Published on 05/02/2026 at 00:00, 1 hour 40 minutes ago

Redwood AI Announces Enhanced AI Models, Increasing Evaluated Chemical Reactions Following Preliminary Results from UBC Collaboration
Published on 05/02/2026 at 00:00, 1 hour 40 minutes ago

Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies
Published on 05/01/2026 at 22:30, 3 hours 10 minutes ago

Nextech3D.ai Appoints New Independent Auditor

View all ACCESSWIRE

Published on 05/01/2026 at 19:23, 6 hours 17 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/01/2026 at 18:40, 7 hours ago

Holding(s) in Company
Published on 05/01/2026 at 17:47, 7 hours 53 minutes ago

Key Figures 30.04.2026
Published on 05/01/2026 at 17:45, 7 hours 55 minutes ago

Burkhalter Group acquires Progressio Holding GmbH and anplaq ag, Tamins (GR)
Published on 05/01/2026 at 17:21, 8 hours 19 minutes ago

Fuller, Smith & Turner PLC: Total Voting Rights and Treasury Shares

View all EQS

Published on 04/30/2026 at 20:00, 1 day 5 hours ago

AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 19:16, 1 day 6 hours ago

AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:00, 1 day 6 hours ago

Capital increase through exercise of subscription rights
Published on 04/30/2026 at 18:10, 1 day 7 hours ago

Minutes of the Combined General Meeting held on April 30, 2026
Published on 04/30/2026 at 18:00, 1 day 7 hours ago

TF1 Q1 2026 results - Press release

View all LES ECHOS COMFI WIRE

News